{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Dublin",
      "state": "OH",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "BLA103976"
        ],
        "brand_name": [
          "XOLAIR"
        ],
        "generic_name": [
          "OMALIZUMAB"
        ],
        "manufacturer_name": [
          "Genentech, Inc."
        ],
        "product_ndc": [
          "50242-040",
          "50242-214",
          "50242-215",
          "50242-227"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "OMALIZUMAB"
        ],
        "rxcui": [
          "1657209",
          "1657212",
          "2058943",
          "2058946",
          "2058949",
          "2058950",
          "2663917",
          "2663918",
          "2663920",
          "2663923",
          "2673760",
          "2673761",
          "2673762",
          "2673763"
        ],
        "spl_id": [
          "e633fdb6-7fbc-4072-93ed-4e30abc6c3a1"
        ],
        "spl_set_id": [
          "7f6a2191-adfb-48b9-9bfa-0d9920479f0d"
        ],
        "package_ndc": [
          "50242-040-62",
          "50242-040-86",
          "50242-214-01",
          "50242-214-86",
          "50242-214-03",
          "50242-214-55",
          "50242-214-99",
          "50242-214-83",
          "50242-215-86",
          "50242-215-01",
          "50242-215-03",
          "50242-215-55",
          "50242-215-99",
          "50242-215-83",
          "50242-227-01",
          "50242-227-55",
          "50242-227-99",
          "50242-227-86"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175794",
          "N0000175793",
          "N0000175792"
        ],
        "pharm_class_epc": [
          "Anti-IgE [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased IgE Activity [PE]"
        ],
        "pharm_class_moa": [
          "IgE-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "2P471X1Z11"
        ]
      },
      "product_type": "Drugs",
      "event_id": "97360",
      "recalling_firm": "Cardinal Health Inc.",
      "address_1": "7000 Cardinal Pl",
      "address_2": "N/A",
      "postal_code": "43017-1091",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide Within the U.S.",
      "recall_number": "D-0572-2025",
      "product_description": "Xolair (omalizumab injection), 75 mg/0.5 ml, Rx only, Genentech, Inc., South San Francisco, CA 94080, NDC 50242-214-55",
      "product_quantity": "4 units",
      "reason_for_recall": "CGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.",
      "recall_initiation_date": "20250730",
      "center_classification_date": "20250807",
      "report_date": "20250813",
      "code_info": "Lot: 3630004, Expires: 10/31/2025.",
      "more_code_info": ""
    }
  ]
}